32 Series D investors targeting Belgium

Compare 32 Series D investors targeting Belgium. Review the selection, investor types and reported focus with 2080 Ventures.

By 2080 Ventures · Updated September 21, 2026

32matching investors

0individual investors

32organizations

What this selection covers

This guide contains 32 distinct directory identities matching target markets: Belgium; funding stages & types: Series D. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Belgium” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Series D is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (30), Family Office (3), Corporate Venture Capital (2), Private Equity (2).

Common reported sector tags: Healthcare (25), SaaS (25), Fintech (22), AI & ML (18). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for Belgium, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Series D, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

Check the current mandate and recent investments.
Confirm check size, lead or follow preference, and company eligibility.
Identify the relevant partner and published pitch route.
Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 32 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

Investor	Investor type	Research
8383North	Venture Capital	View profile ↗
ADAdjuvant Capital	Venture Capital	View profile ↗
ALAlven	Venture Capital	View profile ↗
ARArts Alliance	Family Office, Venture Capital	View profile ↗
ATAtlantic Bridge	Venture Capital	View profile ↗
ATAtomico	Venture Capital	View profile ↗
BABattery Ventures	Venture Capital	View profile ↗
BEBessemer Venture Partners	Venture Capital	View profile ↗
BOBosch Ventures	Venture Capital, Corporate Venture Capital	View profile ↗
CACathay Innovation	Venture Capital	View profile ↗
CRCreandum	Venture Capital	View profile ↗
DADawn Capital	Venture Capital	View profile ↗
DNDN Capital	Venture Capital	View profile ↗
EQEQT Ventures	Venture Capital, Family Office	View profile ↗
FIFinch Capital	Venture Capital	View profile ↗
FOForbion Capital Partners	Venture Capital	View profile ↗
GIGilde Healthcare	Venture Capital	View profile ↗
GIGimv	Private Equity	View profile ↗
GLGlobal Founders Capital	Venture Capital, Family Office	View profile ↗
HEHealthCap	Venture Capital	View profile ↗
IDIDInvest Partners	Private Equity	View profile ↗
INIndex Ventures	Venture Capital	View profile ↗
INInveready	Venture Capital	View profile ↗
NONovo Holdings	Venture Capital, Corporate Venture Capital	View profile ↗
PIPiton Capital	Venture Capital	View profile ↗
PRPrime Ventures	Venture Capital	View profile ↗
PRProject A Ventures	Venture Capital	View profile ↗
SESeventure Partners	Venture Capital	View profile ↗
SUSummit Partners	Venture Capital	View profile ↗
THThe Westly Group	Venture Capital	View profile ↗
VEVentech	Venture Capital	View profile ↗
WEWellington Partners	Venture Capital	View profile ↗